Extracting young people's blood, blood replacement therapy? How wild is the aesthetic medicine boss who was exposed by Haier?

Ask AI · Why has inspirational persona for Yu Wenhong repeatedly fallen into controversy?

Source丨Phoenix Net Finance “Company Research Institute”

On March 30, 2026, Haier Group (Qingdao) Jinying Holding Co., Ltd. (abbreviated as “Haier Jinkong”) issued an emergency statement, pointing the finger at Yu Wenhong, chairman of the Yumeiren Group.

The trigger was very simple: Yu Wenhong publicly claimed that her company is an enterprise of Haier Group and a Yinkang Yisheng investment, and even rolled out the absurd business of “extracting young people’s blood and blood-exchange therapy,” which led many people to believe it.

Haier Jinkong directly stepped in to clarify that Yu Wenhong and Yumeiren have no association with Haier whatsoever, and that all so-called “blood-exchange”-related businesses are unrelated to Haier.

A single announcement pierced the veneer of this “medical-beauty queen,” but it was also just another not-so-new episode in her controversial life.

01

Absurd promotion beneath a motivational facade

Fighting aging with young boys’ plasma, extending life with “immortality needles”—for years, using a set of preposterous and outlandish pseudo-scientific rhetoric, the medical aesthetics boss Yu Wenhong has been harvesting the market.

But once you peel away the marketing gloss, the miraculous anti-aging myth she talks about has long been stamped as a scam by authoritative institutions, hiding deadly health risks.

In her personal autobiography, however, Yu Wenhong packages herself as an inspirational entrepreneur from an ordinary background who started from scratch, and over 30-plus years, has turned a small beauty workshop into a large medical aesthetics business empire spanning across China and abroad.

In 1992, in her early 20s, Yu Wenhong opened a small beauty workshop in Dalian in a space of only 11 square meters, officially stepping into the beauty industry track. The next year, the Yumeiren image studio registered and began operations.

After that, for many years, her business footprint continued to expand.

In 2005, Yumeiren’s nationwide cooperating stores exceeded 150; in 2009, the group’s brand operations center was set up in Hangzhou, and Yu Wenhong became chairman of the board of directors.

In 2011, the brand accelerated internationalization. It successively reached collaborations with institutions in countries including Germany, Japan, and Canada, and established anti-aging centers in Geneva, Switzerland, and in Kowloon Tong, Hong Kong. In 2014, it even fully acquired a Black Forest sanatorium hospital in Germany, extending its business into overseas health and wellness.

Tianyancha data shows that currently Yu Wenhong has as many as 47 personal-associated enterprises, of which 21 have already been deregistered or revoked. Even so, today Yumeiren still has 30 offline clinics across multiple cities nationwide, including Hangzhou, Chengdu, Guangzhou, and Shenzhen.

On one side is the inspirational “comeback” persona shaped by her autobiography; on the other side is false marketing that keeps pushing past the line. Yu Wenhong’s promotion has long slid entirely from conventional medical aesthetics anti-aging into the abyss of pseudo-science scams.

She has long loudly promoted a so-called “blood-exchange anti-aging” technology, claiming it is an exclusive experience for European wealthy circles. Yumeiren built its own exclusive blood bank, extracting functional proteins and microvesicles from the bodies of young male individuals aged 18 to 21. It requires many people’s blood to be purified in order to supply it for a single person, and the pricing is so high that ordinary people can hardly reach it.

She also reveals that she spends 1.5 million yuan per month on blood-exchange maintenance, with a maximum single expenditure reaching 20 million yuan.

Not only the blood-exchange gimmick: in a video from October 2025, she again boldly claimed that the “immortality needle” would be listed in Dubai by the end of the year, asserting that after injection, her condition would be 30 years younger than her boyfriend.

These marketing lines that sound high-end and fantastical are in fact entirely without scientific basis, and they also conceal serious health hazards.

So-called “blood-exchange anti-aging” is, in essence, malicious commercial hype about young plasma infusion therapy.

The concept originated from early experiments in mice where conjoined blood circulation was shared among three generations. After elderly mice shared a blood supply system with young mice, they only showed the temporary appearance of smoother, shinier fur, which is in no way equivalent to “blood-exchange” wellness practices in humans.

The U.S. FDA issued clear warnings as early as 2019: plasma infusion for non-medical uses not only has no clinical anti-aging effect, but also easily causes allergies, abnormalities in coagulation function, and even carries a huge risk of transmitting infectious diseases such as HIV and hepatitis. Silicon Valley tycoon Brian Johnson personally participated in blood-exchange experiments across three generations, with 1 liter of young plasma infused every month. In the end, he publicly confirmed that there were no actual benefits throughout. This once-popular pseudo-scientific farce has long been completely over.

02

Expanding all the way, facing controversy all the way

Yu Wenhong’s business path has always been accompanied by controversy and scrutiny. For years, controversies and incidents have never truly calmed down.

The earliest trace of her controversy goes back more than ten years ago. In 2011, CCTV’s “Focus Interview” pointed to Yu Wenhong in a program titled “The True Face of a Facial Sculpture Master,” stating that she had no practicing physician qualifications yet personally operated to perform plastic surgery, leading to consumers experiencing redness and swelling of the nose after surgery and having ineffective repair.

Two years later, Zhejiang Satellite Television’s “Consumer Insight” once again directed the camera at Yu Wenhong’s Qianhe Medical Beauty clinic and Yumeiren. The report said that the person claiming to be a consultant of the Yumeiren International Group not only refused to present relevant physician qualification certificates, but also refused to show even the doctors’ photos, and was unwilling to disclose information about the primary treating doctor.

Yu Wenhong claimed she was framed due to industry jealousy, but the dispute over practicing qualifications became a label she could not escape.

What truly ignited public opinion was the ongoing cloud of tax evasion for years. In 2022, Hangzhou tax authorities found that Hangzhou Guming Culture, controlled by Yu Wenhong, used 9 personal accounts from 2017 to 2021 to conceal income exceeding 47.55 billion yuan, which was determined as tax evasion. For the underpaid corporate income tax of about 147M yuan, the agency imposed a 60% fine, with total fines amounting to about 88.27 million yuan. The sheer size of the amount shocked the industry.

Her younger brother, Yu Zhongwen, also exposed information to the media. As early as 2015, according to him, Yu Wenhong’s personal account received 169.86 million yuan in just two months—concealed income was far more than only the portion investigated. Yumeiren’s actual revenue could be over 10 billion yuan.

Internal family conflict made the controversy fully public. The siblings fell out because they disagreed on management philosophies and accused each other of misappropriation of duty. In 2024, Yu Zhongwen publicly offered a reward of one million yuan to solicit evidence of Yu Wenhong’s illegal crimes, and said that earlier实名（real-name） tax reports had still not received a clear response for a long time. The family rift was finally laid bare, and Yumeiren’s compliance problems were again brought into focus.

During this period, Yumeiren faced compliance penalties. In 2023, Yumeiren was fined 2 million yuan for illegally publishing medical advertisements and violating pricing rules in livestream rooms.

[Image on the right is Yu Wenhong]

Its channel model has also been heavily criticized: franchisees and service providers go through layered rebates, and customers are gathered for “conference-style marketing,” with charges far above market prices. Industry insiders directly pointed out that it creates information asymmetry and exploits people who want to be beautiful.

In recent years, controversies have continued to ferment. In early 2026, Yu Wenhong was sentenced for online defamation and was ordered to publicly apologize after she made derogatory remarks on a social platform about Zheng Hanwen, founder of Baihui Medical. Recently, Haier Jinkong also urgently refuted rumors, clarifying that Yu Wenhong falsely claimed that Yumeiren received investment from Haier and fabricated false businesses such as “blood-exchange therapy.” It emphasized that the two sides have no cooperation of any kind, and stated that it will pursue legal responsibility in accordance with the law.

From practicing medicine without a license, being penalized for tax evasion, and advertising violations, to the siblings turning on each other—controversies involving Yu Wenhong and Yumeiren run throughout the entire process of her business expansion. On one side is the persona of a “self-made female tycoon,” sitting on a million-plus followers and repeatedly taking high-profile photos with international celebrities; on the other side is a pattern of regulatory penalties and mounting negative associations, making her a typical symbol of controversy in the medical aesthetics industry.

This incident around wealth and compliance has not ended to this day, and it also reflects the hidden risks behind the savage growth of channel-based medical aesthetics.